Cargando…
Clinical value of the systemic immune-inflammation index in moyamoya disease
BACKGROUND: Moyamoya disease (MMD) is a rare cerebrovascular disorder with unknown etiology. The underlying pathophysiological mechanism of moyamoya disease remains to be elucidated, but recent studies have increasingly highlighted that abnormal immune response may be a potential trigger for MMD. Ne...
Autores principales: | Liu, Erheng, Liu, Chengyuan, Jin, Lide, Zhou, Hu, Tan, Xueyi, Zhang, Guibo, Tao, Weihua, Gao, Xiang, Zhao, Heng, Luo, Chao, Li, Xuehua, Yang, Shuaifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157187/ https://www.ncbi.nlm.nih.gov/pubmed/37153657 http://dx.doi.org/10.3389/fneur.2023.1123951 |
Ejemplares similares
-
Research progress on moyamoya disease combined with thyroid diseases
por: Zhang, Guibo, et al.
Publicado: (2023) -
Research progress of moyamoya disease combined with renovascular hypertension
por: Liu, Erheng, et al.
Publicado: (2022) -
Low-dose LPS alleviates early brain injury after SAH by modulating microglial M1/M2 polarization via USP19/FOXO1/IL-10/IL-10R1 signaling
por: Tao, Weihua, et al.
Publicado: (2023) -
Clinical outcomes of pipeline embolization devices with shield technology for treating intracranial aneurysms
por: Luo, Chao, et al.
Publicado: (2022) -
Predictive Value of the Systemic Immune Inflammation Index for Adverse Outcomes in Patients With Acute Ischemic Stroke
por: Zhou, Yun-Xiang, et al.
Publicado: (2022)